RELB and posterior cortical atrophy: Given that BET regulates RelB-BLNK complex levels and considering the high expression levels of RelB and BLNK in PCa patients, as determined by the TCGA database, this study highlights a novel precision medicine approach to reduce the side effects of RT in PCa patients.